Organ-specific isogenic metastatic breast cancer cell lines exhibit distinct Raman spectral signatures and metabolomes
Author(s)
Winnard Jr., Paul T.; Zhang, Chi; Vesuna, Farhad; Garry, Jonah; Barman, Ishan; Raman, Venu; Kang, Jeon Woong; Dasari, Ramachandra Rao; ... Show more Show less
DownloadPaul T. Winnard-2017-Organ-specific isogenic m.pdf (9.713Mb)
PUBLISHER_CC
Publisher with Creative Commons License
Creative Commons Attribution
Terms of use
Metadata
Show full item recordAbstract
Molecular characterization of organ-specific metastatic lesions, which distinguish them from the primary tumor, will provide a better understanding of tissue specific adaptations that regulate metastatic progression. Using an orthotopic xenograft model, we have isolated isogenic metastatic human breast cancer cell lines directly from organ explants that are phenotypically distinct from the primary tumor cell line. Label-free Raman spectroscopy was used and informative spectral bands were ascertained as differentiators of organ-specific metastases as opposed to the presence of a single universal marker. Decision algorithms derived from the Raman spectra unambiguously identified these isogenic cell lines as unique biological entities – a finding reinforced through metabolomic analyses that indicated tissue of origin metabolite distinctions between the cell lines. Notably, complementarity of the metabolomics and Raman datasets was found. Our findings provide evidence that metastatic spread generates tissue-specific adaptations at the molecular level within cancer cells, which can be differentiated with Raman spectroscopy.
Date issued
2017-01Department
Massachusetts Institute of Technology. Department of Chemistry; Massachusetts Institute of Technology. Laser Biomedical Research CenterJournal
Oncotarget
Publisher
Impact Journals/National Center for Biotechnology Information (U.S.)
Citation
Winnard Jr., Paul T. et al. “Organ-Specific Isogenic Metastatic Breast Cancer Cell Lines Exhibit Distinct Raman Spectral Signatures and Metabolomes.” Oncotarget (2017): n. pag.
Version: Final published version
ISSN
1949-2553